Richard E. Lowenthal - 21 Aug 2025 Form 4 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Reporting relationship: PRESIDENT AND CEO, Director, 10%+ Owner
Issuer ticker: SPRY
Reported as of: 21 Aug 2025
Net transaction value: -$724,345
SEC form: 4
Accepted by SEC: 22 Aug 2025, 16:30:16 UTC
Prior SEC filing: 03 Jan 2025
Next SEC filing: 05 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathleen Scott, Attorney-in-Fact

Key filing fact

Richard E. Lowenthal filed Form 4 for ARS Pharmaceuticals, Inc. (SPRY) on 22 Aug 2025.

Key facts

This page summarizes Richard E. Lowenthal's Form 4 filing for ARS Pharmaceuticals, Inc. (SPRY).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Aug 2025, 16:30.

Change

Previous filing in this sequence was filed on 03 Jan 2025.
Current net transaction value: -$724,345.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001378550 Primary reporting owner

Lowenthal Richard E

Relationship: PRESIDENT AND CEO, Director, 10%+ Owner
Address: C/O ARS PHARMACEUTICALS, INC., 11682 EL CAMINO REAL, SUITE 120, SAN DIEGO
Signature: /s/ Kathleen Scott, Attorney-in-Fact
Signature date: 22 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SPRY transaction

Common Stock

Sale

Transaction value: $724,345
Shares: -50,000
Change %: -4%
Price: $14.49
Shares after: 1,196,494
Date: 21 Aug 2025
Ownership: By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020
Footnotes: F1, F2, F3

SPRY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,247,447
Date: 21 Aug 2025
Ownership: By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020
Footnotes: F4

SPRY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,859,200
Date: 21 Aug 2025
Ownership: By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
Footnotes: F5, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on May 15, 2025.

Footnote F2

The weighted average sale price for the transaction reported was $14.4869 and the range of prices were between $14.31 and $14.61. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Footnote F3

The Reporting Person is trustee of the trust.

Footnote F4

The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F5

The number of shares reported is comprised of (i) 1,098,499 shares that were previously reported as indirectly held by the Family Trust, (ii) 3,433,512 shares that were previously reported as indirectly held by the Reporting Person's spouse, and (iii) 4,327,189 shares that were previously reported as directly held by the Reporting Person.

Footnote F6

The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust.